PI
Putnam Investments Portfolio holdings
AUM
$75.7B
1-Year Return
34.47%
This Quarter Return
+13.42%
1 Year Return
+34.47%
3 Year Return
+62.08%
5 Year Return
+203.67%
10 Year Return
+403.53%
AUM
$75.7B
AUM Growth
+$9.96B
(+15%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
2.58%
Top 10 Holdings %
Top 10 Hldgs %
25.53%
Holding
1,266
New
131
Increased
416
Reduced
568
Closed
116
Top Buys
| 1 |
CRH
CRH
|
+$456M |
| 2 |
Boston Scientific
BSX
|
+$397M |
| 3 |
Humana
HUM
|
+$339M |
| 4 |
T-Mobile US
TMUS
|
+$270M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$203M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$479M |
| 2 |
Abbott
ABT
|
+$409M |
| 3 |
Elevance Health
ELV
|
+$395M |
| 4 |
Danaher
DHR
|
+$385M |
| 5 |
Intuit
INTU
|
+$256M |
Sector Composition
| 1 | Technology | 24.54% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 12.81% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Fulgent Genetics
FLGT
$666M
| $647K | ﹤0.01% |
22,363
-3,466
| -13% | -$100K |
|
827
Nurix Therapeutics
NRIX
$690M
| $637K | ﹤0.01% |
+61,717
| New | +$637K |
|
828
Orion
OEC
$569M
| $626K | ﹤0.01% |
22,590
-709
| -3% | -$19.7K |
|
829
Truist Financial
TFC
$58.1B
| $626K | ﹤0.01% |
16,959
-1,574
| -8% | -$58.1K |
|
830
Kite Realty
KRG
$4.96B
| $623K | ﹤0.01% |
+27,267
| New | +$623K |
|
831
Limbach Holdings
LMB
$1.21B
| $622K | ﹤0.01% |
13,690
-427
| -3% | -$19.4K |
|
832
Hanmi Financial
HAFC
$755M
| $600K | ﹤0.01% |
30,922
-971
| -3% | -$18.8K |
|
833
Teekay
TK
$719M
| $599K | ﹤0.01% |
83,756
-2,662
| -3% | -$19K |
|
834
Enova International
ENVA
$2.9B
| $597K | ﹤0.01% |
10,776
-332
| -3% | -$18.4K |
|
835
GrafTech
EAF
$208M
| $585K | ﹤0.01% |
26,719
-851
| -3% | -$18.6K |
|
836
New Jersey Resources
NJR
$4.7B
| $576K | ﹤0.01% |
12,920
+421
| +3% | +$18.8K |
|
837
RE/MAX Holdings
RMAX
$186M
| $575K | ﹤0.01% |
43,119
+25,319
| +142% | +$338K |
|
838
Kinder Morgan
KMI
$60.4B
| $573K | ﹤0.01% |
32,481
-2,062
| -6% | -$36.4K |
|
839
J. Jill
JILL
$269M
| $569K | ﹤0.01% |
+22,057
| New | +$569K |
|
840
Sally Beauty Holdings
SBH
$1.44B
| $556K | ﹤0.01% |
41,867
-64,726
| -61% | -$860K |
|
841
Arrowhead Research
ARWR
$3.91B
| $554K | ﹤0.01% |
18,098
-30,365
| -63% | -$929K |
|
842
Worthington Enterprises
WOR
$3.18B
| $553K | ﹤0.01% |
+9,601
| New | +$553K |
|
843
Titan International
TWI
$542M
| $551K | ﹤0.01% |
37,020
-1,158
| -3% | -$17.2K |
|
844
Castle Biosciences
CSTL
$679M
| $540K | ﹤0.01% |
25,006
-789
| -3% | -$17K |
|
845
CoreCivic
CXW
$2.17B
| $529K | ﹤0.01% |
36,402
-1,143
| -3% | -$16.6K |
|
846
Dyne Therapeutics
DYN
$1.85B
| $526K | ﹤0.01% |
39,536
+2,799
| +8% | +$37.2K |
|
|
SP
847
DELISTED
SP Plus Corporation
SP
| $525K | ﹤0.01% |
10,235
-141,652
| -93% | -$7.26M |
|
|
PDM
848
Piedmont Realty Trust, Inc.
PDM
$1.07B
| $520K | ﹤0.01% |
73,080
-2,314
| -3% | -$16.5K |
|
849
International Bancshares
IBOC
$4.41B
| $518K | ﹤0.01% |
9,541
-297
| -3% | -$16.1K |
|
850
Q2 Holdings
QTWO
$5.19B
| $517K | ﹤0.01% |
11,908
-369
| -3% | -$16K |
|